ATE311871T1 - Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten - Google Patents

Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten

Info

Publication number
ATE311871T1
ATE311871T1 AT97909433T AT97909433T ATE311871T1 AT E311871 T1 ATE311871 T1 AT E311871T1 AT 97909433 T AT97909433 T AT 97909433T AT 97909433 T AT97909433 T AT 97909433T AT E311871 T1 ATE311871 T1 AT E311871T1
Authority
AT
Austria
Prior art keywords
treatment
skin diseases
zinc salts
conjugated linoleic
linoleic acids
Prior art date
Application number
AT97909433T
Other languages
English (en)
Inventor
Derek Bryce-Smith
Original Assignee
Kappa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kappa Pharmaceuticals Ltd filed Critical Kappa Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE311871T1 publication Critical patent/ATE311871T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97909433T 1996-10-17 1997-10-16 Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten ATE311871T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9621630.4A GB9621630D0 (en) 1996-10-17 1996-10-17 Treatment of skin disorders
PCT/GB1997/002854 WO1998017269A1 (en) 1996-10-17 1997-10-16 Use of zinc salts of conjugated linoleic acids to treat skin disorders

Publications (1)

Publication Number Publication Date
ATE311871T1 true ATE311871T1 (de) 2005-12-15

Family

ID=10801560

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97909433T ATE311871T1 (de) 1996-10-17 1997-10-16 Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten

Country Status (10)

Country Link
US (2) US6300374B1 (de)
EP (1) EP1014967B1 (de)
JP (1) JP4243353B2 (de)
AT (1) ATE311871T1 (de)
AU (1) AU718611B2 (de)
DE (1) DE69734838T2 (de)
ES (1) ES2253772T3 (de)
GB (1) GB9621630D0 (de)
NZ (1) NZ334593A (de)
WO (1) WO1998017269A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6019990A (en) * 1997-11-21 2000-02-01 Natural Nutrition Ltd. As Conjugated linoleic acid delivery system in cosmetic preparations
GB9828379D0 (en) * 1998-12-22 1999-02-17 Unilever Plc Skin care composition
GB9828380D0 (en) * 1998-12-22 1999-02-17 Unilever Plc Skin lightening composition
EP1162934A4 (de) * 1999-02-22 2005-01-26 Eric F Bernstein Zusammensetzungen und vefahren zur vorbeugung von lichtalterung
WO2001003688A2 (en) * 1999-07-09 2001-01-18 Pharmacia Corporation Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds
GB9918025D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
GB9918028D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
ITMI991894A1 (it) 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
FR2802099A1 (fr) * 1999-12-08 2001-06-15 Fabre Pierre Cosmetique Thiosalicylate de zinc, compositions dermatologiques le contenant, en particulier sous la forme d'un dispositif auto-adhesif ainsi que le procede de preparation de ce dernier
AU2001256334A1 (en) * 2000-05-05 2001-11-20 Fresenius Kabi Deutschland Gmbh Combination preparation consisting of omega-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs
US20030143165A1 (en) * 2002-01-25 2003-07-31 Allan Evans NSAID-containing topical formulations that demonstrate chemopreventive activity
TW200407172A (en) * 2002-10-17 2004-05-16 Unilever Nv Scalp treatment
EP1583546B1 (de) 2002-10-25 2019-06-19 Precision Dermatology, Inc. Modulation der zinkkonzentrationen zur verbesserung der gewebeeigenschaften
US20080193550A1 (en) * 2004-05-11 2008-08-14 Fonterra Corporate Research And Development Limited Cla-Enriched Milkfat and Uses Thereof
US7767713B2 (en) * 2004-08-05 2010-08-03 Palo Alto Investors Linoleic acid active agents for enhancing probability of becoming pregnant
NZ543486A (en) * 2005-11-10 2009-03-31 Fonterra Corporate Res And Dev Compositions of CIS-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ4032U1 (cs) * 1993-05-17 1995-10-25 Miroslav Ing. Štol Farmaceutická kompozice pro topickou zevní aplikaci
GB9323808D0 (en) 1993-11-18 1994-01-05 Alpha Healthcare Ltd Composition containing zinc for the treatment of skin disorders
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof

Also Published As

Publication number Publication date
US6300374B1 (en) 2001-10-09
JP2001502346A (ja) 2001-02-20
EP1014967B1 (de) 2005-12-07
GB9621630D0 (en) 1996-12-11
JP4243353B2 (ja) 2009-03-25
AU4711997A (en) 1998-05-15
ES2253772T3 (es) 2006-06-01
DE69734838D1 (de) 2006-01-12
US6288115B1 (en) 2001-09-11
AU718611B2 (en) 2000-04-20
DE69734838T2 (de) 2006-08-17
WO1998017269A1 (en) 1998-04-30
EP1014967A1 (de) 2000-07-05
NZ334593A (en) 2000-01-28

Similar Documents

Publication Publication Date Title
ATE321525T1 (de) Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
ATE311871T1 (de) Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten
ATE356113T1 (de) Probucolbernsteinsäureester zur hemmung der expression von vcam-1
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
DE69910560D1 (de) Wasserlöslische prodrugs von 2,6-diisopropylphenol-analoga
DE69914726D1 (de) Zusammensetzung zur regulierung des hauterscheinungsbildes
ATE181913T1 (de) 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-(1)- benzopyran für die behandlung von proliferativer erkrankungen
DE60212964D1 (de) Zusammensetzungen zur behandlung von tierischen krankheiten und syndromen mit transferfaktor
BR9710686A (pt) Método de tratamento de tumores malignos com tiroxinas análogas não possuindo atividade hormonal siginificativa.
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
DE60231050D1 (de) Verwendung von Totarol zur Behandlung von Pruritus
HUT40330A (en) Composition for treating acne and process for producing them
DE69501105D1 (de) L-Carnitin-Salz, dieses enthaltende kosmetische und pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen
DE69806622D1 (de) Kosmetische formulierungen zur verhütung und behandlung von haarausfall
DE69825279D1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
DE69917684D1 (de) Betulinsäure-derivate mit antiangiogener wirkung, verfahren zur herstellung solcher derivate und deren verwendung für die behandlung tumorassoziierter angiogenese
ES2150021T3 (es) Derivados de acidos piridin- y pirazin-dicarboxilicos como reguladores de la proliferacion celular.
DE69229780D1 (de) Zusammensetzung und methode zur behandlung von störungen in form von depigmentierung
DE59508366D1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
DE69932922D1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
DE60027127D1 (de) Verwendung von Polyaminosäurederivaten zur Behandlung von Seborrhoe und verwandten Hautstörungen
DE59900286D1 (de) Verwendung von sphingosin-1-phosphat, sphingosin-1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
DE69900774D1 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties